FUTRUE is an international healthcare group that acts as an incubator for future trends, encompassing over 20 companies and more than 90 drug approvals. They are global leaders in areas such as e-health, microbiome therapy, innovative pain therapies, and chemical-free medicines. Many of their subsidiaries, including SYNformulas and VERTANICAL, are among the fastest-growing healthcare companies in Europe, focusing on developing transformative medicines and technologies.